Oct 2009 | GR21.2May 2009 | GR21.1Oct 2008 | GR20.2May 2008 | GR20.1Dec. 2007 | GR19.2Apr. 2007 | GR19.1Apr. 2007 | GR19.1Jun. 2006 | GR18.1Dec. 2004 | GR17.2Sep. 2004 | GR17.1Nov. 2003 | GR16.2Mar. 2003 | GR16.1Feb. 2002 | GR15.1Feb. 2001 | GR14.1Aug. 2000 | GR13.1Dec. 1999 | GR12.1Dec. 1998 | GR11.2Jul. 1998 | GR11.1Dec. 1997 | GR10.1Dec. 1996 | GR9.1Dec. 1995 | GR8.2Jun. 1995 | GR8.1Sep. 1994 | GR7.1Dec. 1993 | GR6.2May. 1993 | GR6.1
*****Glen Research Glen Report*****
DEPROTECTION – VOLUME 5 – On-Column Deprotection of Oligonucleotides in Organic Solvents
The deprotection of oligonucleotides, especially for high-throughput syntheses, can be the rate-limiting step during the production of oligos and is often difficult to automate due to issues with liquid handling. To streamline the deprotection process, gas phase deprotection using ammonia or methylamine gas is often employed1. After the removal of the protecting groups is complete, the oligo is conveniently eluted directly in water or the buffer of choice. However, the equipment necessary to safely handle a pressurized, corrosive gas is expensive and the additional cost is not worthwhile for many smaller production facilities and research labs.
An alternative method that incorporates much of the convenience of gas-phase deprotection but still utilizes low-cost and simple equipment is On-Column deprotection. In this case, the nucleophilic amine used to remove the protecting groups is dissolved in a non-polar solvent, such as toluene, in which the deprotected oligonucleotide is insoluble. After the deprotection of the oligonucleotide is complete, the column is rinsed, allowed to briefly dry and the oligo, still bound to the support, is eluted in the aqueous buffer of choice, as described by Kempe2. A similar strategy was used by Damha for the deprotection of RNA on glass slides3. Based upon a protocol used to deprotect TC RNA monomers4, we have developed a procedure for the deprotection of standard DNA as shown in the Procedure below:
In Figure 1, we show the results of an oligonucleotide synthesis that was split, with half being deprotected in standard aqueous AMA and the other half in an EDA/toluene solution. Both product oligos had the same molecular weight as determined by electrospray mass spectrometry. We also found there was no drop in yield from the On-Column deprotection compared with the standard aqueous deprotection.
When oligos of the same length but different molecular weights were synthesized on Glen UnySupport Frits and deprotected in the same EDA solution, we found there was no indication of any cross-contamination of oligos between the frits by mass spec analysis. This means that an entire 96 well plate can be conveniently deprotected in a single vessel. It should be noted, however, that the Glen UnySupport required 2 hours at 65 °C to be fully eliminated from the 3' terminus of the oligo in the EDA solution.
We have found that this method is compatible with PS supports as well as CPG supports. However, if there are hydrophobic labels on the product oligo, e.g., DMT or CyDyes, some oligo (10-20%) may be retained on a PS support. In this case, we recommend eluting the oligo in buffer containing 10-20% acetonitrile.
1. J.H. Boal, et al., Nucleic Acids Res., 1996, 24, 3115-3117.
2. T. Kempe, Anhydrous amine cleavage of oligonucleotides. United States Patent 5750672.
3. J.G. Lackey, D. Mitra, M.M. Somoza, F. Cerrina, and M.J. Damha, J. Amer. Chem. Soc., 2009, 131, 8496-502.
4. D.J. Dellinger, personal communication.
Please contact Glen Research if you have any questions or comments!